Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment

American Journal of Kidney Diseases

Volumn 68, Issue 1, 2016, Pages 19-28

  Vijayan, Anitha ^a   Faubel, Sarah ^b   Askenazi, David J ^c   Cerda, Jorge ^d   Fissell, William H ^e   Heung, Michael ^f   Humphreys, Benjamin D ^a   Koyner, Jay L ^g   Liu, Kathleen D ^h   Mour, Girish ⁱ   Nolin, Thomas D ^j   Bihorac, Azra ^k   Basu, Rajit K ^l   Bhatt, Udayan Y ^l   Connor, Michael J ^l   Davidson, Alan J ^l   De Caestecker, Mark P ^l   Doi, Kent ^l   Golestaneh, Ladan ^l   Mour, Girish K ^l   Singh, Prabhleen ^l   Thakar, Charuhas V ^l   more..

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d ALBANY MEDICAL COLLEGE   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF CHICAGO   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF PITTSBURGH   (United States)

^k UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^l NONE

more..

Author keywords

Acute kidney injury (AKI); biomarker; critically ill; decreased kidney function; diagnosis; early detection; insulin like growth factor binding protein 7; NephroCheck; renal dysfunction; risk assessment; tissue inhibitor of metalloproteinase 2; TIMP 2 IGFBP7

Indexed keywords

INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 7; SOMATOMEDIN BINDING PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-RELATED PROTEIN 1; TIMP2 PROTEIN, HUMAN;

ACUTE KIDNEY FAILURE; ARTICLE; CELL CYCLE ARREST; COST BENEFIT ANALYSIS; HUMAN; MULTICENTER STUDY (TOPIC); PROTEIN FUNCTION; RISK ASSESSMENT; ACUTE KIDNEY INJURY; CLINICAL TRIAL (TOPIC); DECISION TREE; EARLY DIAGNOSIS; PROCEDURES; URINE;

ACUTE KIDNEY INJURY; BIOMARKERS; CLINICAL TRIALS AS TOPIC; DECISION TREES; EARLY DIAGNOSIS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; RISK ASSESSMENT; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84959467506     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.12.033     Document Type: Article

References (78)

1. L.S. Chawla, R.L. Amdur, A.D. Shaw, C. Faselis, C.E. Palant, and P.L. Kimmel Association between AKI and long-term renal and cardiovascular outcomes in United States veterans Clin J Am Soc Nephrol 9 2014 448 456
2. G. Chertow, E. Levy, K. Hammermeister, F. Grover, and J. Daley Independent association between acute renal failure and mortality following cardiac surgery Am J Med 104 1998 343 348
3. S. Uchino, J.A. Kellum, R. Bellomo, and et al. Acute renal failure in critically ill patients: a multinational, multicenter study JAMA 294 2005 813 818
4. J.L. Koyner, J. Cerda, S.L. Goldstein, and et al. The daily burden of acute kidney injury: a survey of US nephrologists on World Kidney Day Am J Kidney Dis 64 2014 394 401
5. American Society of Nephrology The American Society of Nephrology renal research report J Am Soc Nephrol 16 2005 1886 1903
6. S.M. Moran, and B.D. Myers Course of acute renal failure studied by a model of creatinine kinetics Kidney Int 27 1985 928 937
7. S.S. Waikar, R.A. Betensky, S.C. Emerson, and J.V. Bonventre Imperfect gold standards for kidney injury biomarker evaluation J Am Soc Nephrol 23 2012 13 21
8. C.R. Parikh, P. Devarajan, M. Zappitelli, and et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery J Am Soc Nephrol 22 2011 1737 1747
9. C.R. Parikh, S.G. Coca, H. Thiessen-Philbrook, and et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery J Am Soc Nephrol 22 2011 1748 1757
10. E.D. Siew, L.B. Ware, T. Gebretsadik, and et al. Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults J Am Soc Nephrol 20 2009 1823 1832
11. K. Kashani, A. Al-Khafaji, T. Ardiles, and et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury Crit Care 17 2013 R25
12. T.L. Nickolas, K.M. Schmidt-Ott, P. Canetta, and et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study J Am Coll Cardiol 59 2012 246 255
13. US Food and Drug Administration. News release "FDA allows marketing of the first test to assess risk of developing acute kidney injury." September 5, 2014. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm412910.htm. Accessed May 11, 2015.
14. A. Bihorac, L.S. Chawla, A.D. Shaw, and et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication Am J Respir Crit Care Med 189 2014 932 939
15. D.W. Seo, H. Li, L. Guedez, and et al. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism Cell 114 2003 171 180
16. D.W. Seo, H. Li, C.K. Qu, and et al. Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells J Biol Chem 281 2006 3711 3721
17. J. Barasch, J. Yang, J. Qiao, and et al. Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros J Clin Invest 103 1999 1299 1307
18. R. Engers, E. Springer, F. Michiels, J.G. Collard, and H.E. Gabbert Rac affects invasion of human renal cell carcinomas by up-regulating tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2 expression J Biol Chem 276 2001 41889 41897
19. V. Hwa, Y. Oh, and R.G. Rosenfeld The insulin-like growth factor-binding protein (IGFBP) superfamily Endocr Rev 20 1999 761 787
20. N. Wajapeyee, V. Kapoor, M. Mahalingam, and M.R. Green Efficacy of IGFBP7 for treatment of metastatic melanoma and other cancers in mouse models and human cell lines Mol Cancer Ther 8 2009 3009 3014
21. S. Zuo, C. Liu, J. Wang, and et al. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells J Cancer Res Clin Oncol 138 2012 1045 1055
22. Y. Liu, W. Guo, J. Zhang, and et al. Urinary interleukin 18 for detection of acute kidney injury: a meta-analysis Am J Kidney Dis 62 2013 1058 1067
23. J. Vanmassenhove, R. Vanholder, E. Nagler, and W. Van Biesen Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature Nephrol Dial Transplant 28 2013 254 273
24. M. Ostermann, B.J. Philips, and L.G. Forni Clinical review: biomarkers of acute kidney injury: where are we now? Crit Care 16 2012 233
25. M.E. Wasung, L.S. Chawla, and M. Madero Biomarkers of renal function, which and when? Clin Chim Acta 438 2015 350 357
26. J.R. Charlton, D. Portilla, and M.D. Okusa A basic science view of acute kidney injury biomarkers Nephrol Dial Transplant 29 2014 1301 1311
27. J.L. Koyner, and C.R. Parikh Clinical utility of biomarkers of AKI in cardiac surgery and critical illness Clin J Am Soc Nephrol 8 2013 1034 1042
28. H.R. de Geus, M.G. Betjes, and J. Bakker Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges Clin Kidney J 5 2012 102 108
29. F. Gonzalez, and F. Vincent Biomarkers for acute kidney injury in critically ill patients Minerva Anestesiol 78 2012 1394 1403
30. S. Herget-Rosenthal, J. Metzger, A. Albalat, V. Bitsika, and H. Mischak Proteomic biomarkers for the early detection of acute kidney injury Prilozi 33 2012 27 48
31. E.A. Hoste, P.A. McCullough, K. Kashani, and et al. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers Nephrol Dial Transplant 29 2014 2054 2061
32. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group Clinical practice guideline for acute kidney injury Kidney Int Suppl 2 2012 1 138
33. J. Xia, D.I. Broadhurst, M. Wilson, and D.S. Wishart Translational biomarker discovery in clinical metabolomics: an introductory tutorial Metabolomics 9 2013 280 299
34. J.W. Pickering, M.T. James, and S.C. Palmer Acute kidney injury and prognosis after cardiopulmonary bypass: a meta-analysis of cohort studies Am J Kidney Dis 65 2015 283 293
35. A. Zarbock, C. Schmidt, H. Van Aken, and et al. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial JAMA 313 2015 2133 2141
36. M. Meersch, C. Schmidt, H. Van Aken, and et al. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery PLoS One 9 2014 e93460
37. A.J. Wetz, E.M. Richardt, S. Wand, and et al. Quantification of urinary TIMP-2 and IGFBP-7: an adequate diagnostic test to predict acute kidney injury after cardiac surgery? Crit Care 19 2015 3
38. M. Meersch, C. Schmidt, H. Van Aken, and et al. Validation of cell-cycle arrest biomarkers for acute kidney injury after pediatric cardiac surgery PLoS One 9 2014 e110865
39. I. Gocze, M. Koch, P. Renner, and et al. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery PLoS One 10 2015 e0120863
40. L.S. Chawla, D.L. Davison, E. Brasha-Mitchell, and et al. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury Crit Care 17 2013 R207
41. J.L. Koyner, D.L. Davison, E. Brasha-Mitchell, and et al. Furosemide stress test and biomarkers for the prediction of AKI severity J Am Soc Nephrol 26 2015 2023 2031
42. US Food and Drug Administration. Letter to Astute Medical September 5, 2014. http://www.accessdata.fda.gov/cdrh-docs/pdf13/den130031.pdf. Accessed May 11, 2015.
43. ® Test Kit Package Insert. 2014 PN 300152 Rev E 2014/09/05. http://www.astutemedical.com/content/documents/us/NephroCheck-Test-Package-Insert-US-IVD-PN-300152)-RevE.pdf; Accessed February 5, 2016.
44. ® test system decision summary. http://www.accessdata.fda.gov/cdrh-docs/reviews/den130031.pdf. Accessed May 11, 2015.
45. R.H. Thiele, J.M. Isbell, and M.H. Rosner AKI associated with cardiac surgery Clin J Am Soc Nephrol 10 2015 500 514
46. K. Lusky AKI risk biomarkers may be "as early as it gets." CAP Today June:12-16, 2015 http://digital.olivesoftware.com/Olive/ODE/CAPTODAY/ Accessed July 10, 2015
47. C. Hobson, T. Ozrazgat-Baslanti, A. Kuxhausen, and et al. Cost and mortality associated with postoperative acute kidney injury Ann Surg 261 2015 1207 1214
48. Section 3: Prevention and treatment of AKI. In: KDIGO clinical practice guideline for acute kidney injury: prevention and treatment of AKI. Kidney Int Suppl. 2012;2:37-68.
49. N. Flynn, and A. Dawnay A simple electronic alert for acute kidney injury Ann Clin Biochem 52 2015 206 212
50. M.E. Thomas, C. Blaine, A. Dawnay, and et al. The definition of acute kidney injury and its use in practice Kidney Int 87 2015 62 73
51. K. Wallace, A.S. Mallard, J.D. Stratton, P.A. Johnston, S. Dickinson, and R.G. Parry Use of an electronic alert to identify patients with acute kidney injury Clin Med 14 2014 22 26
52. F.P. Wilson, M. Shashaty, J. Testani, and et al. Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial Lancet 385 2015 1966 1974
53. D. Ponce, P. Zorzenon Cde, N.Y. dos Santos, and A.L. Balbi Early nephrology consultation can have an impact on outcome of acute kidney injury patients Nephrol Dial Transplant 26 2011 3202 3206
54. R.L. Mehta, B. McDonald, F. Gabbai, and et al. Nephrology consultation in acute renal failure: does timing matter? Am J Med 113 2002 456 461
55. P. Meier, R.M. Bonfils, B. Vogt, B. Burnand, and M. Burnier Referral patterns and outcomes in noncritically ill patients with hospital-acquired acute kidney injury Clin J Am Soc Nephrol 6 2011 2215 2225
56. G. Balasubramanian, Z. Al-Aly, A. Moiz, and et al. Early nephrologist involvement in hospital-acquired acute kidney injury: a pilot study Am J Kidney Dis 57 2011 228 234
57. M.A. Perazella, S.G. Coca, I.E. Hall, U. Iyanam, M. Koraishy, and C.R. Parikh Urine microscopy is associated with severity and worsening of acute kidney injury in hospitalized patients Clin J Am Soc Nephrol 5 2010 402 408
58. M.A. Perazella The urine sediment as a biomarker of kidney disease Am J Kidney Dis 66 2015 748 755
59. H.Y. Tiong, P. Huang, S. Xiong, Y. Li, A. Vathsala, and D. Zink Drug-induced nephrotoxicity: clinical impact and preclinical in vitro models Mol Pharm 11 2014 1933 1948
60. M.A. Perazella Drug use and nephrotoxicity in the intensive care unit Kidney Int 81 2012 1172 1178
61. S.K. Jo, M.H. Rosner, and M.D. Okusa Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon Clin J Am Soc Nephrol 2 2007 356 365
62. T. Bove, A. Zangrillo, F. Guarracino, and et al. Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial JAMA 312 2014 2244 2253
63. R. Hirschberg, J. Kopple, P. Lipsett, and et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure Kidney Int 55 1999 2423 2432
64. J. Lewis, M.M. Salem, G.M. Chertow, and et al. Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group Am J Kidney Dis 36 2000 767 774
65. J.V. Bonventre, D. Basile, K.D. Liu, and et al. AKI: a path forward Clin J Am Soc Nephrol 8 2013 1606 1608
66. S.S. Soni, C. Ronco, N. Katz, and D.N. Cruz Early diagnosis of acute kidney injury: the promise of novel biomarkers Blood Purif 28 2009 165 174
67. I.E. Hall, S.G. Yarlagadda, S.G. Coca, and et al. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation J Am Soc Nephrol 21 2010 189 197
68. J.L. Koyner, V.S. Vaidya, M.R. Bennett, and et al. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury Clin J Am Soc Nephrol 5 2010 2154 2165
69. C.R. Parikh, A. Jani, J. Mishra, and et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation Am J Transplant 6 2006 1639 1645
70. C.R. Parikh, J. Mishra, H. Thiessen-Philbrook, and et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery Kidney Int 70 2006 199 203
71. D. Portilla, C. Dent, T. Sugaya, and et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery Kidney Int 73 2008 465 472
72. K. Doi, E. Noiri, R. Maeda-Mamiya, and et al. Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury Crit Care Med 38 2010 2037 2042
73. P. Susantitaphong, M. Siribamrungwong, K. Doi, E. Noiri, N. Terrin, and B.L. Jaber Performance of urinary liver-type fatty acid-binding protein in acute kidney injury: a meta-analysis Am J Kidney Dis 61 2013 430 439
74. S.K. Parr, A.J. Clark, A. Bian, and et al. Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury Kidney Int 87 2015 640 648
75. I. Torregrosa, C. Montoliu, A. Urios, and et al. Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography Heart Vessels 30 6 2015 703 711
76. Y. Du, M. Zappitelli, A. Mian, and et al. Urinary biomarkers to detect acute kidney injury in the pediatric emergency center Pediatr Nephrol 26 2011 267 274
77. X.L. Liang, S.X. Liu, Y.H. Chen, and et al. Combination of urinary kidney injury molecule-1 and interleukin-18 as early biomarker for the diagnosis and progressive assessment of acute kidney injury following cardiopulmonary bypass surgery: a prospective nested case-control study Biomarkers 15 2010 332 339
78. O. Liangos, H. Tighiouart, M.C. Perianayagam, and et al. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass Biomarkers 14 2009 423 431